Does the Indian variant of Sars-CoV-2, B1.617.2, have the capacity to escape vaccines? Is it really more transmissible than the Kent variant, and by how much? Those are the urgent questions which government scientific advisers are going to have to try to answer over the next week or two – and the answers will have profound consequences for life in Britain over the next few months.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in